HEAL seeks to provide investors exposure to the growing HealthTech industry, which is expected to grow fourfold from $225 billion in 2022 to over $1 trillion by 2032.

According to a new market research report titled, "Postbiotics Market Size, Share, Forecast, & Trends Analysis by Type (Bacteria, Yeast), Form (Liquid, Dry), Application (Food & Beverages, Nutritional ...

Seismic Therapeutic has dosed the first healthy participant cohort in the randomised Phase I trial of bifunctional antibody S ...

Viking Therapeutics, Inc.'s VK2735 has potential as a GLP-1 for obesity amid Pfizer's exit, but competition and financing ...

The global Deuterated Drugs Market is witnessing remarkable momentum as it charts a growth trajectory from a valuation of US$ 334.0 million in 2023 to an anticipated US$ 871.8 million by 2032, ...

GemPharmatech, a global leader in genetically engineered mouse models and preclinical contract research services, today ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

The VIX, known as the stock market's fear gauge, has soared in recent days. Stocks crumbled again on Friday after the worst loss since 2020.

Nurix Therapeutics (NRIX) announced that the U.S. Food and Drug Administration, FDA, has cleared the IND for the IRAK4 degrader ...

Rein Therapeutics (RNTX) announced a publication highlighting the therapeutic potential of Caveolin-1-related peptide LTI-2355 in Idiopathic ...

To identify potential therapeutic targets, this study investigated the molecular and immune landscape of three chondrosarcoma subtypes using a large database of clinical-grade sequencing results.